Novel Therapies for Unmet Clinical Needs in Myelodysplastic Syndromes

Novel Therapies for Unmet Clinical Needs in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are a very heterogeneous disease, with extremely variable clinical features and outcomes. Current management relies on risk stratification based on IPSS and IPSS-R, which categorizes patients into low (LR-) and high-risk (HR-) MDS. Therapeutic strategies in LR-MDS pat...

Full description

Bibliographic Details
Main Authors: Giulio Cassanello, Raffaella Pasquale, Wilma Barcellini, Bruno Fattizzo
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
myelodysplastic syndromes
unmet needs
target therapy
somatic mutations
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/14/19/4941

Internet

https://www.mdpi.com/2072-6694/14/19/4941

Similar Items